drugset / Trial / NCT04500015
Vaginal Isonicotinic Acid Hydrazide Administration Prior to Intrauterine Device Insertion
RandomizedParallel-groupQuadruple-blindPrevention
Summary
To investigate whether vaginal isonicotinic acid hydrazide administered before the levonorgestrel-releasing intrauterine system insertion reduces IUD insertion pain and difficulty in insertion in adolescents and young women.
Timeline
- Start
- 2020-09-01
- Primary completion
- 2021-06-30
- Completion
- 2021-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isonicotinic Acid Hydrazide | Unknown | 3 unknown | Other |